Christine H Chung1, Ashley Bagheri2, Gypsyamber D'Souza3. 1. Department of Oncology, Johns Hopkins Medical Institute, Baltimore, MD, United States; Department of Otolaryngology, Head and Neck Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institute, Baltimore, MD, United States. 2. Department of Oncology, Johns Hopkins Medical Institute, Baltimore, MD, United States. 3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: gdsouza@jhsph.edu.
Abstract
OBJECTIVE: To describe what is known about the epidemiology of oral human papillomavirus (HPV) infection. METHODS: In this article we review current data on HPV prevalence, natural history, mode of acquisition, and risk factors for oral HPV infection. RESULTS & CONCLUSION: Over the past several years new studies have informed our understanding of oral HPV infection. These data suggest oral HPV prevalence is higher in men than women and support the sexual transmission of HPV to the mouth by oral sex. Data is emerging suggesting that most oral HPV infections usually clear within a year on and describing risk factors for prevalent and persistent infection. Recent data support likely efficacy of the HPV vaccine for oral HPV, suggesting vaccination may reduce risk of HPV-related oropharyngeal cancer.
OBJECTIVE: To describe what is known about the epidemiology of oral human papillomavirus (HPV) infection. METHODS: In this article we review current data on HPV prevalence, natural history, mode of acquisition, and risk factors for oral HPV infection. RESULTS & CONCLUSION: Over the past several years new studies have informed our understanding of oral HPV infection. These data suggest oral HPV prevalence is higher in men than women and support the sexual transmission of HPV to the mouth by oral sex. Data is emerging suggesting that most oral HPV infections usually clear within a year on and describing risk factors for prevalent and persistent infection. Recent data support likely efficacy of the HPV vaccine for oral HPV, suggesting vaccination may reduce risk of HPV-related oropharyngeal cancer.
Authors: Susan Hariri; Elizabeth R Unger; Maya Sternberg; Eileen F Dunne; David Swan; Sonya Patel; Lauri E Markowitz Journal: J Infect Dis Date: 2011-08-15 Impact factor: 5.226
Authors: Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek Journal: Cancer Causes Control Date: 2010-04-17 Impact factor: 2.506
Authors: Aimée R Kreimer; Rohini K Bhatia; Andrea L Messeguer; Paula González; Rolando Herrero; Anna R Giuliano Journal: Sex Transm Dis Date: 2010-06 Impact factor: 2.830
Authors: Zoe R Edelstein; Stephen M Schwartz; Stephen Hawes; James P Hughes; Qinghua Feng; Michael E Stern; Sandra O'Reilly; Shu-Kuang Lee; Long Fu Xi; Laura A Koutsky Journal: Sex Transm Dis Date: 2012-11 Impact factor: 2.830
Authors: Saverio G Parisi; Mario Cruciani; Renzo Scaggiante; Caterina Boldrin; Samantha Andreis; Federico Dal Bello; Silvana Pagni; Andrea Barelli; Andrea Sattin; Carlo Mengoli; Giorgio Palù Journal: BMC Infect Dis Date: 2011-05-25 Impact factor: 3.090
Authors: Holdunn Rutkoski; Brynn Fowler; Ryan Mooney; Lisa Pappas; Barbara L Dixon; Lilliam M Pinzon; James Winkler; Deanna Kepka Journal: J Cancer Educ Date: 2018-08 Impact factor: 2.037